nwrd08
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 7, 2022 (NCT05905354)
Timeline
Indications
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07175662 | Phase 2 | Oct 10, 2025 | Government of China |
| NCT06276101 | Phase 1 | Jan 25, 2024 | Chinese Academy of Medical Sciences, Newish Technology (Beijing) Co.,Ltd. |
| NCT05905354 | N/A | Mar 7, 2022 | Newish Technology (Beijing) Co.,Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Newish Technology (Beijing) Co.,Ltd. | Government | 2 | 2 | 2 | 2022 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1